News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
155 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17699)
Month
January (2478)
February (2705)
March (2920)
April (2815)
May (3257)
June (3002)
July (2537)
August (2870)
September (2818)
October (3675)
November (3195)
December (2498)
Day
1 (69)
5 (131)
6 (139)
7 (157)
8 (120)
11 (137)
12 (155)
13 (148)
14 (146)
15 (105)
16 (1)
18 (163)
19 (161)
20 (147)
21 (144)
22 (111)
23 (2)
25 (152)
26 (192)
27 (157)
28 (161)
29 (120)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
5
6
7
8
11
12
13
14
15
16
18
19
20
21
22
23
25
26
27
28
29
Business
Bristol-Myers Squibb Company Board Of Directors Announces Departure Of Peter R. Dolan As CEO And Appointment Of James M. Cornelius As Interim CEO
September 12, 2006
·
3 min read
Genetown
Curis, Inc. Announces New Cancer Programs, Formation Of China-Based Subsidiary
September 12, 2006
·
12 min read
Drug Development
Valeant Pharmaceuticals International Reports VISER2 Results For Viramidine(R); Drug Does Not Meet Efficacy Goal
September 12, 2006
·
7 min read
Vasogen To Present At The A.G. Edwards’ Emerging Growth Conference
September 12, 2006
·
1 min read
Policy
KV Pharmaceutical Company Receives ANDA Approval From U.S. FDA For Six Strengths Of Diltiazem HCl ER Capsules
September 12, 2006
·
1 min read
Deals
LAB Research Inc. Closes Over-Allotment Option To Complete $46 Million Initial Public Offering
September 12, 2006
·
1 min read
BioForest
Seattle-Area Physician Performs Region’s First Successful Outpatient, Herniated Disc Decompression Using Breakthrough, Minimally Invasive Fluidjet Technology Manufactured By Hydrocision
September 12, 2006
·
1 min read
Policy
Acambis PLC Receives $19 Million From Novartis To Settle ARILVAX Dispute
September 12, 2006
·
1 min read
Pluristem Life Systems Inc. Selected To Present At International Society for Experimental Hematology Meeting
September 12, 2006
·
1 min read
Drug Development
Biophan Technologies, Inc. Release: Research Demonstrates Ability Of The MYO-VAD(TM) To Help Prevent Progression Of Heart Disease; Paper Presented By Mark A. Anstadt, M.D. Describes Animal Studies
September 12, 2006
·
1 min read
Previous
10 of 16
Next